Search Medical Condition
Please enter condition
Please choose location from dropdown

Mexico D.F.C.P., Mexico Clinical Trials

A listing of Mexico D.F.C.P., Mexico clinical trials actively recruiting patients volunteers.

RESULTS

Found (330) clinical trials

Subcutaneous Nitroglycerin to Facilitate Trans-radial Access.

Unlike femoral access, the trans-radial approach to coronary angiography requires a greater learning curve for the inexperienced interventionist, and demands a greater technical challenge than the femoral approach, which leads to a high incidence of failures and complications, mainly in the initial stages of their formation. Some explanations for procedural ...

Phase

1.26 miles

Learn More »

Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate

The purpose of this study is to provide access to palbociclib in Mexico and in selected Latin American countries before it becomes commercially available to patients with HR positive/HER2-negative ABC who are appropriate candidates for letrozole therapy.

Phase

2.07 miles

Learn More »

Comparison High-Density Silicone Oils in Retinal Detachment

Five to 10% of retinal detachments progressed to proliferative vitreoretinopathy (PVR), the common more cause of surgical failure of retina detachment. Despite the use of internal tamponades, the treatment of retinal detachments due to a progressed proliferative vitreoretinopathy (PVR) is still a problem. At present, conventional silicone oil, having a ...

Phase

2.46 miles

Learn More »

Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment

Introduction: The concept of retinal photocoagulation was introduced by Meyer-Schwickerath for treatment of diabetic retinopathy in the 50s (1, 6). The first successfully used laser was the arc xenon laser (polychromatic, inefficient, and hard to handle). Then the ruby and argon laser appeared (with mayor improvements in design and management). ...

Phase

2.48 miles

Learn More »

Changes in Macular Thickness After Patterns Scan Laser

Introduction: The concept of retinal photocoagulation was introduced by Meyer-Schwickerath for treatment of diabetic retinopathy in the 50s (1, 6). The first successfully used laser was the arc xenon laser (polychromatic, inefficient, and hard to handle). Then the ruby and argon laser appeared (with mayor improvements in design and management). ...

Phase

2.48 miles

Learn More »

Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO

Comparison of two groups with different treatment with registrations of outcome in BCVA and complications

Phase

2.48 miles

Learn More »

POSTERIOR SUB-TENON'S Avastin

Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema

Phase

2.48 miles

Learn More »

Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema

To Evaluate combined effect of vitrectomy and bevacizumab to stabilize retinal thickness and visual acuity in patients with diffuse diabetic macular edema and their relation to renal disease.

Phase

2.48 miles

Learn More »

Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study

Diabetic macular edema is the most common cause of visual loss among patients with diabetic retinopathy. Pars plana vitrectomy has been reported to be effective for the treatment of diabetic macular edema. Previous report showed a limited improvement in visual acuity and macular thickness posterior intraoperative triamcinolone acetonide. Bevacizumab intravitreal ...

Phase

2.48 miles

Learn More »

Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

Purpose:Retinopathy of prematurity (ROP) continues tobe a major cause of blindness in children. Although ablation of the retina with laser or cryotherapy reduces the incidence of blindness by suppressing the neovascular phase of ROP the visual outcomes after treatment are often poor. Vascular endothelial growth factor(VEGF) has an important role ...

Phase

2.48 miles

Learn More »